Placebo letrozole

DRUG2 trials

Sponsors

F. Hoffmann-La Roche AG, Hongxia Ma

Conditions

ESTROGEN RECEPTOR-POSITIVEHER2-NEGATIVE LOCALLY ADVANCED OR METASTATIC BREAST CANCERPolycystic Ovary Syndrome

Phase 3

A Trial of Personalized Acupuncture, Fixed Acupuncture, Letrozole and Placebo on Live Birth in Women With PCOS

CompletedNCT03625531

Hongxia MaPolycystic Ovary Syndrome

Start: 2018-08-13End: 2025-01-22Updated: 2026-04-14

A PHASE III RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTER STUDY EVALUATING THE EFFICACY AND SAFETY OF GDC-9545 COMBINED WITH PALBOCICLIB COMPARED WITH LETROZOLE COMBINED WITH PALBOCICLIB IN PATIENTS WITH ESTROGEN RECEPTOR-POSITIVE, HER2-NEGATIVE LOCALLY ADVANCED OR METASTATIC BREAST CANCER

Active, not recruitingCTIS2023-506911-16-00

F. Hoffmann-La Roche AGESTROGEN RECEPTOR-POSITIVE, HER2-NEGATIVE LOCALLY ADVANCED OR METASTATIC BREAST CANCER

Start: 2020-12-04Target: 259Updated: 2025-12-16

Related Papers

A multicenter randomized trial of personalized acupuncture, fixed acupuncture, letrozole, and placebo letrozole on live birth in infertile women with polycystic ovary syndrome

Trials2020-03-0418 citations